KISHA COOK: Open Payments
NPI 1568986404 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 19 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $435 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 8 | $257 |
| Otsuka America Pharmaceutical, Inc. | 7 | $222 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 2 | $31 |
Products named: Qelbree, REXULTI, CAPLYTA, SPRAVATO.
Industry payments across NJ — which companies pay providers there.
